Stock Scorecard
Stock Summary for Johnson & Johnson (JNJ) - $144.88 as of 4/18/2024 7:04:29 PM EST
Total Score
15 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for JNJ
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JNJ
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JNJ
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for JNJ
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for JNJ
Financial Details for JNJ
Company Overview |
|
---|---|
Ticker | JNJ |
Company Name | Johnson & Johnson |
Country | USA |
Description | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 144.88 |
Last Day Price Updated | 4/18/2024 7:04:29 PM EST |
Last Day Volume | 9,378,059 |
Average Daily Volume | 7,262,081 |
52-Week High | 173.31 |
52-Week Low | 143.39 |
Last Price to 52 Week Low | 1.04% |
Valuation Measures |
|
Trailing PE | 27.78 |
Industry PE | 100.90 |
Sector PE | 61.34 |
5-Year Average PE | 13.20 |
Free Cash Flow Ratio | 12.74 |
Industry Free Cash Flow Ratio | 12.66 |
Sector Free Cash Flow Ratio | 30.16 |
Current Ratio Most Recent Quarter | 1.16 |
Total Cash Per Share | 11.37 |
Book Value Per Share Most Recent Quarter | 28.57 |
Price to Book Ratio | 5.17 |
Industry Price to Book Ratio | 5.66 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 4.17 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.19 |
Share Statistics |
|
Total Shares Outstanding | 2,409,780,000 |
Market Capitalization | 349,128,926,400 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 2/16/2024 |
Last Dividend Amount | 1.19 |
Current Dividend Amount | 1.24 |
Dividend Aristocrat? | |
Trailing Annual Dividend Rate | 6.00 |
Trailing Annual Dividend Yield | 4.14% |
Forward Annual Dividend Rate | 6.35 |
Forward Annual Dividend Yield | 4.39% |
5-Year Dividend Payments Count | 21 |
3-Year Average Dividend Yield | 2.66% |
5-Year Average Dividend Yield | 2.61% |
1-Year Dividend Growth Rate Percentage | 5.62% |
3-Year Dividend Growth Rate Percentage | 5.91% |
5-Year Dividend Growth Rate Percentage | 5.81% |
All-Time Dividend Growth Rate Percentage | 13.21% |
Dividend Payout Ratio | 115.61% |
Income Statement |
|
Quarterly Earnings Growth YOY | 10.60% |
Annual Earnings Growth | 95.94% |
Reported EPS 12 Trailing Months | 5.20 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 10.43 |
Net Income Twelve Trailing Months | 35,153,000,000 |
Net Income Past Year | 35,153,000,000 |
Net Income Prior Year | 17,941,000,000 |
Quarterly Revenue Growth YOY | 7.30% |
5-Year Revenue Growth | 0.91% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 27,400,000,000 |
Total Cash Past Year | 27,400,000,000 |
Total Cash Prior Year | 24,095,000,000 |
Net Cash Position Most Recent Quarter | 50,000,000 |
Net Cash Position Past Year | 50,000,000 |
Long Term Debt Past Year | 27,350,000,000 |
Long Term Debt Prior Year | 28,437,000,000 |
Total Debt Most Recent Quarter | 27,350,000,000 |
Equity to Debt Ratio Past Year | 0.72 |
Equity to Debt Ratio Most Recent Quarter | 0.72 |
Total Stockholder Equity Past Year | 68,774,000,000 |
Total Stockholder Equity Prior Year | 76,804,000,000 |
Total Stockholder Equity Most Recent Quarter | 68,774,000,000 |
Options |
|
Put/Call Ratio | 4.20 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -1.81 |
MACD Signal | -1.19 |
20-Day Bollinger Lower Band | 150.16 |
20-Day Bollinger Middle Band | 156.90 |
20-Day Bollinger Upper Band | 163.64 |
Beta | 0.53 |
RSI | 30.92 |
50-Day SMA | 156.97 |
200-Day SMA | 154.53 |
System |
|
Modified | 4/18/2024 3:58:41 AM EST |